4//SEC Filing
Marek David C 4
Accession 0001209191-22-024784
CIK 0001679082other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 4:46 PM ET
Size
7.6 KB
Accession
0001209191-22-024784
Insider Transaction Report
Form 4
Marek David C
DirectorPrincipal Executive Officer
Transactions
- Award
Common Shares
2022-04-15+134,567→ 472,550 total - Award
Stock Option (Right to Buy)
2022-04-15+204,808→ 204,808 totalExercise: $11.33Exp: 2032-04-14→ Common Shares (204,808 underlying)
Footnotes (2)
- [F1]The Common Shares are to be acquired upon the vesting of certain Restricted Stock Units ("RSUs") granted to the Reporting Person. 1/4 of the common shares underlying the RSUs vest on April 15, 2023, and 1/16 of the common shares underlying the RSUs vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.
- [F2]1/4 of the common shares underlying this option vest on April 15, 2023, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.
Documents
Issuer
Myovant Sciences Ltd.
CIK 0001679082
Entity typeother
Related Parties
1- filerCIK 0001556914
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 4:46 PM ET
- Size
- 7.6 KB